Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1

Status

Recruiting 2Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Rectal Neoplasms 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Glioma 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Astrocytoma 3Sarcoma 2Pancreatic Neoplasms 2Osteosarcoma 2Lung Neoplasms 2Carcinoma, Squamous Cell 2Brain Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Rhabdomyosarcoma 1Recurrence 1Radiation Injuries 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Postoperative Complications 1Pilonidal Sinus 1

Interventions

Oxaliplatin 25Fluorouracil 20Capecitabine 17Nivolumab 16pembrolizumab 15Leucovorin 13Trastuzumab 9fludarabine 8S 1 (combination) 8Paclitaxel 8Drug Therapy 8Docetaxel 8Cyclophosphamide 8Specimen Handling 7trastuzumab deruxtecan 6Cisplatin 6Magnetic Resonance Spectroscopy 5Biopsy 5Bevacizumab 5zolbetuximab 4Irinotecan 4zimberelimab 3sintilimab 3fludarabine phosphate 3atezolizumab 3aldesleukin 3XELOX 3Surgical Procedures, Operative 3Ramucirumab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Stomach Neoplasms × Surgical Procedures, Operative × 90 days × Clear all
NCT07000253 2026-05-07

OMEC-5

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2/3 Recruiting
290 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT06576921 2026-04-23

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Xijing Hospital

Phase 2 Recruiting
116 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡